Last reviewed · How we verify
3% 2-chloroprocaine and epidural morphine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
3% 2-chloroprocaine and epidural morphine (3% 2-chloroprocaine and epidural morphine) — The University of Texas Health Science Center, Houston.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 3% 2-chloroprocaine and epidural morphine TARGET | 3% 2-chloroprocaine and epidural morphine | The University of Texas Health Science Center, Houston | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 3% 2-chloroprocaine and epidural morphine CI watch — RSS
- 3% 2-chloroprocaine and epidural morphine CI watch — Atom
- 3% 2-chloroprocaine and epidural morphine CI watch — JSON
- 3% 2-chloroprocaine and epidural morphine alone — RSS
Cite this brief
Drug Landscape (2026). 3% 2-chloroprocaine and epidural morphine — Competitive Intelligence Brief. https://druglandscape.com/ci/3-2-chloroprocaine-and-epidural-morphine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab